Pfizer RSV vaccine wins recommendation for seasonal use only
Pfizer’s new shot to protect infants against respiratory syncytial virus by vaccinating their mothers late in pregnancy won a limited recommendation Friday from an expert panel that advises the Centers for Disease Control and Prevention, clearing the way for a second product to protect babies against RSV to soon hit the market.
The recommendation must be accepted by CDC Director Mandy Cohen before the vaccine can begin to be used. Cohen was expected to sign off on the recommendation later Friday.
Read Original Article: Pfizer RSV vaccine wins recommendation for seasonal use only »
